T cell-depleted unrelated donor stem cell transplantation provides favorable disease-free survival for adults with hematologic malignancies
about
Effects of T-Cell Depletion on Allogeneic Hematopoietic Stem Cell Transplantation Outcomes in AML PatientsOutcomes from unrelated donor hematopoietic stem cell transplantationLong term renal survival in patients undergoing T-Cell depleted versus conventional hematopoietic stem cell transplants.Adenovirus viremia and disease: comparison of T cell-depleted and conventional hematopoietic stem cell transplantation recipients from a single institution.Ex vivo T cell-depleted versus unmodified allografts in patients with acute myeloid leukemia in first complete remission.Relationship of BK polyoma virus (BKV) in the urine with hemorrhagic cystitis and renal function in recipients of T Cell-depleted peripheral blood and cord blood stem cell transplantationsIntestinal domination and the risk of bacteremia in patients undergoing allogeneic hematopoietic stem cell transplantationAdvance care planning among hematopoietic cell transplant patients and bereaved caregivers.Early Clostridium difficile infection during allogeneic hematopoietic stem cell transplantation.Intestinal Blautia Is Associated with Reduced Death from Graft-versus-Host DiseaseHave we improved in preventing and treating acute graft-versus-host disease?CD34+ selection and the severity of oropharyngeal mucositis in total body irradiation-based allogeneic stem cell transplantationPrevention of graft-vs.-host diseaseCellular therapies in acute lymphoblastic leukemiaCD34-Selected Hematopoietic Stem Cell Transplants Conditioned with Myeloablative Regimens and Antithymocyte Globulin for Advanced Myelodysplastic Syndrome: Limited Graft-versus-Host Disease without Increased RelapseHigh Disease-Free Survival with Enhanced Protection against Relapse after Double-Unit Cord Blood Transplantation When Compared with T Cell-Depleted Unrelated Donor Transplantation in Patients with Acute Leukemia and Chronic Myelogenous Leukemia.Allogeneic transplantation: peripheral blood vs. bone marrow.Concise review: acute graft-versus-host disease: immunobiology, prevention, and treatment.Strategies to reduce relapse after allogeneic hematopoietic cell transplantation in acute myeloid leukemia.Histopathologic Features of Cutaneous Acute Graft-Versus-Host Disease in T-Cell-Depleted Peripheral Blood Stem Cell Transplant Recipients.Advances in the treatment of acute graft-versus-host disease.Predictive factors for rapid neutrophil and platelet engraftment after allogenic peripheral blood stem cell transplantation in patients with acute leukemia.T-cell depleted allogeneic hematopoietic cell transplants as a platform for adoptive therapy with leukemia selective or virus-specific T-cells.The evolution of T-cell depletion in haploidentical stem-cell transplantation.Ex vivo T-cell depletion in allogeneic hematopoietic stem cell transplant: past, present and future.How do I perform hematopoietic progenitor cell selection?Early recovery of T-cell function predicts improved survival after T-cell depleted allogeneic transplant.Allogeneic hematopoietic stem cell transplantation for nonmalignant hematologic disorders using chemotherapy-only cytoreductive regimens and T-cell-depleted grafts from human leukocyte antigen-matched or -mismatched donorsA Chemotherapy-Only Regimen of Busulfan, Melphalan, and Fludarabine, and Rabbit Antithymocyte Globulin Followed by Allogeneic T-Cell Depleted Hematopoietic Stem Cell Transplantations for the Treatment of Myeloid Malignancies.Co-Infections by Double-Stranded DNA Viruses after Ex Vivo T Cell-Depleted, CD34+ Selected Hematopoietic Cell Transplantation.Ex Vivo CD34+-Selected T Cell-Depleted Peripheral Blood Stem Cell Grafts for Allogeneic Hematopoietic Stem Cell Transplantation in Acute Leukemia and Myelodysplastic Syndrome Is Associated with Low Incidence of Acute and Chronic Graft-versus-Host DiCytomegalovirus Infection after CD34(+)-Selected Hematopoietic Cell Transplantation.Low incidence of GvHD with T-cell depleted allografts facilitates further treatments for post-transplantation relapse in AML and MDS.Ten-year follow-up of pediatric patients with non-Hodgkin lymphoma treated with allogeneic or autologous stem cell transplantation.Long-term prognosis for 1-year relapse-free survivors of CD34+ cell-selected allogeneic hematopoietic stem cell transplantation: a landmark analysis.Blood and Marrow Transplant Clinical Trials Network Report on the Development of Novel Endpoints and Selection of Promising Approaches for Graft-versus-Host Disease Prevention Trials.Ex vivo and in vivo T cell-depleted allogeneic stem cell transplantation in patients with acute myeloid leukemia in first complete remission resulted in similar overall survival: on behalf of the ALWP of the EBMT and the MSKCCT cell depletion utilizing CD34+ stem cell selection and CD3+ addback from unrelated adult donors in paediatric allogeneic stem cell transplantation recipients
P2860
Q26799602-307460C5-838D-4CD9-9FA2-773889181A9DQ27027854-FC544285-D065-457D-B65E-B36CED8D8E25Q33633514-E78F2756-714E-4849-9F21-5C61B0DEB4EFQ33726613-725E7EBC-B186-42FA-B7E6-E18E95B542BFQ33760933-BE691D6A-FBDB-442B-BD75-8CEDDFF6CE91Q33905299-BD0A8C92-2ED0-49A9-99AF-2737B49CEC9DQ34311369-27BE6855-B055-459F-806C-A089E210548EQ34315455-0C1A821C-4C48-4BDD-A8B6-71AF2ACA060FQ35129079-9EEF7B23-BF40-4E53-ACD2-847683DB949FQ35892249-7F8D65FF-7061-4D54-9555-E5F2253EF8F1Q36203692-991889AB-B8DE-41F4-BAFB-B045FA0073B4Q36403184-5F17AAA7-A2B3-420D-BA84-49C23F952D53Q36431047-11279724-6091-45AA-A858-27D5EB83EADCQ36552098-52C1B3B2-C4BB-483D-937E-D870D2C65DBFQ36608689-EC1ACB2C-9E8E-4160-8C97-55F50B207CBAQ36622322-8C50DEE5-5038-4B0D-89DD-9D88221795D7Q36761427-C3728303-829B-468F-B504-8CB65439E856Q36861714-5F1D56D0-37B0-4E21-9A53-006F05FA576EQ37000485-5B69A3DA-ADC0-43F9-87E3-0E81E87F59AFQ37139105-C4D246E0-1301-45CD-8A34-87AAAA3E9E8FQ37191057-03929629-B0A6-4AE0-8E73-CA493451033FQ38448204-9ECA195E-1190-49D5-B850-A2A32F8C33ADQ38514497-55F5F93B-122F-4D56-8F61-3F3A1EFE21ACQ38673780-0F990F3D-8E93-4295-B140-7A9A7A2CAC5DQ38742867-E734B365-F202-416D-8F35-F5BC7B71E6A0Q38751575-FFC1F25F-2ED2-4842-BBE9-786E0F495ABBQ39028818-144EC7C2-E269-43D0-A540-67B1EEFA5D45Q39313203-69334090-1E56-4D6A-9728-22BE2EFAE8E9Q40121414-D0EF7C05-4F30-4B39-96DB-930B5D167651Q40138389-0F890F75-6CC0-4F31-AFC6-6687E7B20536Q40407930-5DEEEB37-518E-47A0-9167-BA01387494BAQ40674993-7F81013D-04B0-4628-A8FC-9D331272CC8DQ40881086-95C2F62C-22E7-4582-ADD4-0FC5A1A537DFQ44647479-24569754-C014-49F5-98DB-331DC9B3AFD6Q49391428-6B468564-C617-4808-ACD1-CB399C7E75D3Q50079874-D203BACC-0B44-4133-B5B3-743EF51FA928Q57808500-B26E150F-72D3-47C3-A709-A4932091694DQ58449860-807E7D0D-8615-4992-97A7-08AFD94E3884
P2860
T cell-depleted unrelated donor stem cell transplantation provides favorable disease-free survival for adults with hematologic malignancies
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
T cell-depleted unrelated dono ...... with hematologic malignancies
@ast
T cell-depleted unrelated dono ...... with hematologic malignancies
@en
T cell-depleted unrelated dono ...... with hematologic malignancies
@nl
type
label
T cell-depleted unrelated dono ...... with hematologic malignancies
@ast
T cell-depleted unrelated dono ...... with hematologic malignancies
@en
T cell-depleted unrelated dono ...... with hematologic malignancies
@nl
prefLabel
T cell-depleted unrelated dono ...... with hematologic malignancies
@ast
T cell-depleted unrelated dono ...... with hematologic malignancies
@en
T cell-depleted unrelated dono ...... with hematologic malignancies
@nl
P2093
P2860
P1476
T cell-depleted unrelated dono ...... with hematologic malignancies
@en
P2093
Ann A Jakubowski
Esperanza B Papadopoulos
Guenther Koehne
Hugo Castro-Malaspina
James W Young
Katharine C Hsu
Marcel R M van den Brink
Miguel A Perales
Nancy Collins
Richard J O'Reilly
P2860
P304
P356
10.1016/J.BBMT.2011.01.005
P577
2011-01-11T00:00:00Z